# Ovid Therapeutics Inc. (OVID)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/OVID/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 733.0K | $ -32.00M | $ -31.49M | $ 12.72M | $ 209.89M |
| 2025 | $ 7.43M | $ -17.83M | $ -39.25M | $ 13.42M | $ 130.66M |
| 2024 | $ 594.9K | $ -27.78M | $ -58.89M | $ 14.76M | $ 68.23M |
| 2023 | $ 423.9K | $ -56.59M | $ -49.53M | $ 16.00M | $ 87.80M |
| 2022 | $ 1.68M | $ -60.51M | $ -63.25M | $ 16.54M | $ 132.27M |
| 2021 | $ 247.69M | $ 147.02M | $ 140.76M | $ 0 | $ 179.75M |
| 2020 | $ 16.07M | $ -103.23M | $ -66.21M | $ 0 | $ 43.63M |
| 2019 | $ 0 | $ -78.04M | $ -66.26M | $ 0 | $ 70.02M |
| 2018 | $ 0 | $ -68.65M | $ -60.63M | $ 0 | $ 38.81M |
| 2017 | $ 0 | $ -87.30M | $ -42.56M | $ 0 | $ 83.44M |
| 2016 | $ 0 | $ -30.84M | $ -24.75M | $ 0 | $ 49.29M |
| 2015 | $ 0 | $ -4.62M | $ -2.94M | $ 0 | $ 68.07M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.06 |
| Liabilities / Eq | 0.11 |
| Current Ratio | 12.39 |

## Other views

- [Metrics](https://sponda.capital/en/OVID.md)
- [Charts](https://sponda.capital/en/OVID/charts.md)
- [Compare](https://sponda.capital/en/OVID/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.